Schedule 13G ownership disclosure

Ventyx Biosciences Inc

Common Stock, par value $0.0001 per share · CUSIP: 92332V107

Event date: 2025-05-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Affinity Healthcare Fund, LP

    Shares: 4,057,105.00 · Class: 5.70%

  • Affinity Asset Advisors, LLC

    Shares: 4,057,105.00 · Class: 5.70%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-25-006966
Form type
SCHEDULE 13G
Filer
Affinity Asset Advisors, LLC
CIK
CIK 1773195
Filed
May 30, 2025
Reporting period
May 22, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub